Design of Coelenterazine Analogue to Reveal Bioluminescent Reaction of Human Serum Albumin
Design of Coelenterazine Analogue to Reveal Bioluminescent Reaction of Human Serum Albumin
复制标题
DOI:
10.5772/intechopen.97232
复制
发表时间:
2021-04
期刊:
影响因子:
--
通讯作者:
Ryohei Nishihara;K. Niwa;Tatsunosuke Tomita;R. Kurita
中科院分区:
文献类型:
--
作者:
Ryohei Nishihara;K. Niwa;Tatsunosuke Tomita;R. Kurita
This chapter describes the design of an imidazopyrazinone-type luciferin named as HuLumino1 by us and investigation of its luminescence properties. This luciferin was designed to generate bioluminescence by human serum albumin (HSA) rather than by luciferase derived from luminous organisms. HuLumino1 was developed by modifying a methoxy-terminated alkyl chain to the C-6 position and eliminating a benzyl group at the C-8 position of coelenterazine. To clarify the basis of light emission by HSA, the detailed kinetic properties of the HuLumino1/HSA pair were investigated using a calibrated luminometer. The enzymatic oxidation of HuLumino1 was observed only in the presence of HSA. Results of HSA quantification experiments using HuLumino1 agreed with less than 5% differences with those of enzyme-linked immunosorbent assays, suggesting HuLumino1 could be used for quantitative analysis of HSA levels in serum samples without any pretreatments. These results demonstrate the advantages of the coelenterazine analogue as a bioluminescence reagent to detect non-labeled proteins, which generally do not function as enzymes.